SCHEMBL9378702

SCHEMBL9378702

C[C@H](NC(=O)OCc1ccccc1)C(=O)Nc1sccc1C(=O)c1ccccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSK P43235 5/20 0.46
LMNA P02545 5/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HTT P42858 3/20 0.43
CTSS P25774 5/20 0.43
CTSL P07711 4/20 0.43
CYP1A2 P05177 1/20 0.43
CTSB P07858 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 1/20 0.42
PTPN7 P35236 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRK1 P41145 1/20 0.42
DUSP3 P51452 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10407184 1.00 CTSK (0.46) CTSKLMNAMEN1KMT2AALDH1A1
SCHEMBL8908677 0.86 CTSK (0.52) CTSKLMNAMEN1KMT2ACTSS
SCHEMBL9039756 0.82 ALDH1A1 (0.40) CTSKLMNAMEN1KMT2AALDH1A1
SCHEMBL9038885 0.82 CTSK (0.41) CTSKLMNAMEN1KMT2AALDH1A1
SCHEMBL20369888 0.75 MAPK8 (0.48) CTSKLMNAMEN1KMT2AALDH1A1
SCHEMBL11055593 0.74 MEN1 (0.61) CTSKLMNAMEN1KMT2ACTSS
SCHEMBL9669324 0.74 PTK2 (0.58) ALDH1A1KDM4E
SCHEMBL11493783 0.72 MAPK8 (0.53) LMNAMEN1KMT2AALDH1A1HTT
SCHEMBL11655203 0.71 LMNA (0.53) LMNAMEN1KMT2AALDH1A1HTT
SCHEMBL23604935 0.71 CTSK (0.63) CTSKLMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0320992-B1 Triazolodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-07-27 EP disclosed
US-4959361-A Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists HOFFMANN-LA ROCHE INC. (US) 1990-09-25 US disclosed
EP-0320992-A2 Triazolodiazepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-06-21 EP disclosed